Peptide Ligands | Sequence | Receptor Specificity | Activity | Species |
---|---|---|---|---|
Human galanin (1–30) | GWTLNSAGYLLGPHAVGNHRSFSDKNGLTS | none | agonist | |
Rat galanin (1–29) | GWTLNSAGYLLGPHAIDNHRSFSDKHGLT | none | agonist | |
Porcine galanin (1–29) | GWTLNSAGYLLGPHAIDNHRSFHDKYGLA | none | agonist | |
Galanin (2–11) (AR-M1896) | WTLNSAGYLL | GAL2/GAL3a,b | agonista | rat |
C7 = galanin (1–13)-spantide I | GWTLNSAGYLLGPRPKPQQWFWLL | none | antagonistc | rat |
M15 = galantide= galanin (1–13)-substance P (5–11) amide | GWTLNSAGYLLGPQQFFGLM | none | antagonistd | rat |
M32 = galanin (1–13)-neuropeptide Y (25–36) amide | GWTLNSAGYLLGPRHYINLITRQRY | none | antagoniste | rat |
M35 = galanin(1–13)-bradykinin(2–9) amide | GWTLNSAGYLLGPPPGFSPFR | none | antagonistf | rat |
M40 = Galanin (1–13)-Pro-Pro-(Ala-Leu-)2Ala amide | GWTLNSAGYLLGPALALA | none | antagonistc,g | rat |
M617 = galanin(1–13)-Gln14-bradykinin(2–9) amide | GWTLNSAGYLLGPQPGFSPFR | GAL1>GAL2 | agonisth,i | rat |
M871 = galanin (2–13)-Glu-His-(Pro)3(Ala-Leu)2Ala amide | WTLNSAGYLLGPEHPPPALALA | GAL2j,k | antagonisti | rat |
M1160 | RGRGNWLNSAGYLLGPVLPPPALALA | GAL2l | agonistl | mouse |
J18 | RGRGNWTLNSAGYLLGPkkK(eNH_C(O)stearic acid)k | GAL2>GAL3>GAL1 | agonistm | mouse |
Gal-B2 (NAX 5055) | (Sar)WTLNSAGYLLGPKKKpalmitoylK | GAL1>GAL2n | agonisto | mouse |
[N-Me, des-Sar]Gal-B2 | N-MeWTLNSAGYLLGPKKKpalmitoylK | GAL2>GAL1n | agonistp | mouse |
Gal-S2 | (Sar)WTLNSAGYLLGPXKKKX | nonen | Agonistq | mouse |
Human galanin-like peptide GALP (1–60) | APAHRGRGGWTLNSAGYLLGPVLHLPQMGDQDGKRETALEILDLWKAIDGLPYSHPPQPS | noner | agonists | mouse |
Human GALP (3–32) | AHRGRGGWTLNSAGYLLGPVLHLPQMGDQ | noner,n | agonists | mouse |
↵a Liu et al. (2001).
↵b Lu et al. (2005b).
↵c Crawley et al. (1993).
↵d Bartfai et al. (1991).
↵e Xu et al. (1995a).
↵f Wiesenfeld-Hallin et al. (1992).
↵g Leibowitz and Kim (1992).
↵h Lundström et al. (2005b).
↵i Jimenez-Andrade et al. (2006).
↵j Sollenberg et al. (2006).
↵k Sollenberg et al. (2010).
↵l Saar et al. (2013b).
↵m Saar et al. (2013b).
↵n Not tested for GAL3; X = (S)-2-(4-pentenyl)alanine.
↵o Bulaj et al. (2008).
↵p Robertson et al. (2010).
↵q Green et al. (2013).
↵r Lang et al. (2005).
↵s Schmidhuber et al. (2007).